136 related articles for article (PubMed ID: 21476873)
1. Pharmacokinetics and metabolism update for some recent antipsychotics.
Caccia S
Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):829-46. PubMed ID: 21476873
[TBL] [Abstract][Full Text] [Related]
2. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
[TBL] [Abstract][Full Text] [Related]
3. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
[TBL] [Abstract][Full Text] [Related]
4. Lurasidone: a new drug in development for schizophrenia.
Meyer JM; Loebel AD; Schweizer E
Expert Opin Investig Drugs; 2009 Nov; 18(11):1715-26. PubMed ID: 19780705
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
6. Focus on aripiprazole.
Green B
Curr Med Res Opin; 2004; 20(2):207-13. PubMed ID: 15006016
[TBL] [Abstract][Full Text] [Related]
7. Potential use of lurasidone for the treatment of bipolar psychosis.
Carta MG; Moro MF; Nardi AE; Calabrese JR
Expert Opin Investig Drugs; 2015 Apr; 24(4):575-84. PubMed ID: 25633339
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole: a review of its pharmacology and clinical use.
Taylor DM
Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
[TBL] [Abstract][Full Text] [Related]
9. [Aripiprazole use in children and adolescent psychiatric patients].
Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D;
Therapie; 2011; 66(2):123-30. PubMed ID: 21635859
[TBL] [Abstract][Full Text] [Related]
10. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic.
Citrome L
Clin Schizophr Relat Psychoses; 2011 Jan; 4(4):251-7. PubMed ID: 21177242
[TBL] [Abstract][Full Text] [Related]
11. [Aripiprazole: a new atypical antipsychotic drug].
Fischer B; Davids E; Gastpar M
Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
[TBL] [Abstract][Full Text] [Related]
12. Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.
Bobo WV
Expert Rev Clin Pharmacol; 2013 Jan; 6(1):61-91. PubMed ID: 23272794
[TBL] [Abstract][Full Text] [Related]
13. Role of aripiprazole in treating mood disorders.
García-Amador M; Pacchiarotti I; Valentí M; Sanchez RF; Goikolea JM; Vieta E
Expert Rev Neurother; 2006 Dec; 6(12):1777-83. PubMed ID: 17181424
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats.
Lee KR; Chae YJ; Koo TS
Xenobiotica; 2011 Dec; 41(12):1100-7. PubMed ID: 21838595
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
[TBL] [Abstract][Full Text] [Related]
17. A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone.
Umene-Nakano W; Yoshimura R; Hori H; Okamoto T; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):273. PubMed ID: 20849906
[No Abstract] [Full Text] [Related]
18. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
[TBL] [Abstract][Full Text] [Related]
19. Introduction. Ziprasidone appears to offer important therapeutic and tolerability advantages over conventional, and some novel, antipsychotics.
Tandon R
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):1S-3S. PubMed ID: 10771447
[No Abstract] [Full Text] [Related]
20. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.
Wisniewski CS; Robert S
Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
